Non-invasive diagnostics for cancer screening and triage.
Non-invasive diagnostics for cancer screening and triage.
Point01 Biosciences is a Houston-based cancer diagnostics company developing blood- and urine-based assay programs for screening, triage, and risk stratification across selected solid tumor indications.
Point01 Biosciences is a Houston-based cancer diagnostics company developing blood- and urine-based assay programs for screening, triage, and risk stratification across selected solid tumor indications.
Developing assay programs for clinically actionable triage.
Developing assay programs for clinically actionable triage.
Point01 develops non-invasive diagnostics designed to support clinical decision pathways where molecular testing can help identify patients who may benefit from further diagnostic workup, surveillance, or de-escalation.
Our programs focus on blood- and urine-based assay formats, clinically evaluated biomarker assets, and evidence generation designed for real-world diagnostic adoption.
Point01 develops non-invasive diagnostics designed to support clinical decision pathways where molecular testing can help identify patients who may benefit from further diagnostic workup, surveillance, or de-escalation.
Our programs focus on blood- and urine-based assay formats, clinically evaluated biomarker assets, and evidence generation designed for real-world diagnostic adoption.
Overview
Overview
We focus exclusively on non-invasive cancer diagnostics.
We focus exclusively on non-invasive cancer diagnostics.
Approach
Assay development for clinically actionable triage.
Sampling formats
Biomarker assets
Triage workflows
Evidence path
Sampling formats
Biomarker assets
Triage workflows
Evidence path
Mission
Mission
Building diagnostics for cancer interception.
Building diagnostics for cancer interception.
Catch cancer earlier, when intervention matters most
Catch cancer earlier, when intervention matters most
Route at-risk patients to the right next step
Route at-risk patients to the right next step
Reduce unnecessary invasive procedures through smarter triage
Reduce unnecessary invasive procedures through smarter triage
Team & expertise
Built to advance assays from evidence to implementation.
Point01 brings together experience across oncology diagnostics, molecular assay development, clinical validation, laboratory operations, health economics, reimbursement, market access, and commercialization. Our team is focused on translating clinically evaluated biomarker assets into scalable, evidence-driven diagnostic assays.
Assay development & lab operations
Clinical validation & evidence generation
Market access & commercialization
